dactinomycin has been researched along with Osteogenic Sarcoma in 138 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 79 (57.25) | 18.7374 |
| 1990's | 41 (29.71) | 18.2507 |
| 2000's | 12 (8.70) | 29.6817 |
| 2010's | 5 (3.62) | 24.3611 |
| 2020's | 1 (0.72) | 2.80 |
| Authors | Studies |
|---|---|
| Csikos, C; Hegedűs, C; Kiss, A; Polgár, Z; Regdon, Z; Virág, L | 1 |
| Burchill, SA; Jabri, S; Roundhill, EA | 1 |
| Cai, HQ; Li, YC; Wang, ZG; Xu, YL; Yang, J | 1 |
| Choi, YJ; Lee, HW; Lee, YS; Seo, SW; Shim, da M | 1 |
| Cho, Y; Choi, Y; Chung, SH; Jung, GH; Kim, JD; Kim, JY | 1 |
| Bao, CF; Li, XH; Yang, LM | 1 |
| Ayala, AG; Devidas, M; Gebhardt, MC; Goorin, AM; Grier, HE; Harris, MB; Helman, LJ; Link, MP; Schwartzentruber, DJ | 1 |
| D'ANGIO, GJ | 1 |
| ROCHLIN, DB | 1 |
| NAHUM, AM | 1 |
| Goto, T; Hozumi, T; Kobayashi, H; Kondo, T; Kosaku, H | 1 |
| Goi, K; Hamada, Y; Inukai, T; Nakazawa, S; Sato, H; Sugita, K; Tezuka, T; Uno, K | 1 |
| Bashir, H; Crom, D; Hudson, MM; Jones, D; Metzger, M; Mulcahey, J | 1 |
| Bacci, G; Balladelli, A; Bertoni, F; Briccoli, A; Ferrari, S; Forni, C; Longhi, A; Mercuri, M; Picci, P; Serra, M | 1 |
| Barbieri, S; Derenzini, M; Donati, G; Govoni, M; Mazzini, G; Montanaro, L; Nardi-Pantoli, A; Treré, D; Vici, M | 1 |
| Goto, T; Hozumi, T; Kondo, T; Nakada, I; Okuma, T | 1 |
| Blondet, R; Bouffet, E; Brunat-Mentigny, M; Chauvot, P; Moyen, B; Philip, T | 1 |
| Abeling, NG; Behrendt, H; Cranendonk, E; van Gennip, AH | 1 |
| Jürgens, H; Rosen, G | 1 |
| Cacavio, A; Caparros, B; Huvos, AG; Kosloff, C; Lane, JM; Marcove, RC; Mehta, B; Nirenberg, A; Rosen, G; Urban, C | 1 |
| Beck, J; Beck, W; Beron, G; Brandeis, W; Ebell, W; Erttmann, R; Göbel, U; Havers, W; Henze, G; Hinderfield, L; Höcker, P; Jobke, A; Jürgens, H; Kabisch, H; Kotz, R; Landbeck, G; Preusser, P; Prindull, G; Ramach, W; Ritter, J; Salzer-Kuntschik, M; Sekera, J; Treuner, J; Winkler, K; Wüst, G | 1 |
| Souhami, RL | 1 |
| Beck, J; Beck, W; Beron, G; Brandeis, W; Ebell, W; Erttmann, R; Göbel, U; Kotz, R; Salzer-Kuntschik, M; Winkler, K | 1 |
| Cacavio, A; Caparros, B; Groshen, S; Huvos, AG; Lane, JM; Marcove, RC; Nirenberg, A; Rosen, G | 1 |
| Pan, LC; Price, PA | 1 |
| Kaye, SB; Ryman, BE | 1 |
| Boden, JA; Kaye, SB; Ryman, BE | 1 |
| Corbett, TH; Griswold, DP; Laster, WR; Schabel, FM; Skipper, HE; Trader, MW | 1 |
| Carpentier, AF; Chantelard, JV; Henin, D; Poisson, M | 1 |
| Link, MP | 1 |
| Bielack, SS; Delling, G; Jürgens, H; Kotz, R; Salzer-Kuntschik, M; Winkler, K | 1 |
| Krailo, M; Miser, JS | 1 |
| Avella, M; Bacci, G; Casadei, R; Cazzola, A; Ferrari, S; Lari, S; Monti, C; Picci, P; Prever, BA; Ruggieri, P | 1 |
| Heller, G; Meyers, PA; Vlamis, V | 1 |
| Delepine, G; Delepine, N; Desbois, JC | 1 |
| Contesso, G; Edeline, V; Kalifa, C; Lemerle, J; Razafindrakoto, H; Valteau, D; Vanel, D; Vassal, G | 1 |
| Ekert, H; Tiedemann, K | 1 |
| Göeken, LN; Kamps, WA; Molenaar, WM; Postma, A; Schraffordt Koops, H; Veth, RP | 1 |
| Bloem, JL; Doornbos, J; Hermans, J; Holscher, HC; Nooy, MA; van der Woude, HJ | 1 |
| Bos, G; Brown, D; Fletcher, WS; Lebredo, L; Moseley, HS; Small, K; Woltering, EA | 1 |
| Goorin, A; Hallowell, JA; Kharasch, VS; Lipsitz, S; Santis, W | 1 |
| Baum, ES; Betcher, DL; Ettinger, LJ; Huvos, AG; Kisker, CT; Krailo, MD; Makley, JT; Miser, JS; Nachman, JB; Provisor, AJ; Yunis, EJ | 1 |
| Denhardt, DT; Kageyama, R; Matsue, M; Noda, M | 1 |
| Epstein, JI; North, RB; Sipos, EP; Tamargo, RJ | 1 |
| Kwon, HJ; Sawamura, M; Schreiber, SL; Shimada, J | 1 |
| Drüeke, TB; Yaghoobian, J | 1 |
| Busch, H; Cai, ZJ; Henning, D; Perlaky, L; Valdez, BC | 1 |
| Casper, E; Gorlick, R; Healey, JH; Heller, G; Huvos, AG; Lane, J; Meyers, PA | 1 |
| Egawa, K; Kunimoto, S; Nishigori, H; Nose, K; Takeuchi, T | 1 |
| La Thangue, NB; Lee, CW | 1 |
| Haneji, T; Kido, H; Kobayashi, S; Morimoto, H; Morimoto, Y; Ohba, T | 1 |
| Ben Abdallah, M; Ben Ayed, F; Ben Ghachem, M; Ben Hamida, H; Ben Hassine, H; Ben Romdhane, K; Boussen, H; Daldoul, O; Douik, M; Gamoudi, A; Karray, S; Khalfallah, S; Mezlini, A; Mezzi, F; Saadi, A | 1 |
| Liu, C; Watson, CE; Werth, VP; Williams, KJ; Zhang, W | 1 |
| Gebski, V; Machin, D; Tai, BC; White, I | 1 |
| Arbizu, J; López de Mesa, R; Narbona, J; Sánchez-Carpintero, R; Sierrasesúmaga, L | 1 |
| Albrecht, RM; Bertics, PJ; Mellon, WS; Mosavin, R; Rivera-Bermúdez, MA | 1 |
| Ise, T | 1 |
| Caparros, B; Gutierrez, M; Mosende, C; Rosen, G | 1 |
| Laster, WR; Rose, WC; Schabel, FM; Trader, MW | 1 |
| Rosen, G | 3 |
| Blasková, L; Krizan, I; Krizan, Z; Látal, J; Majeský, B; Makai, F | 1 |
| Evans, AE | 1 |
| Ahmann, DL; Bisel, HF; Creagan, ET; Eagan, RT; Edmonson, JH; Hahn, RG | 1 |
| Afridi, MA; Douglass, H; Friedman, M; Wallace, JH | 1 |
| Cassady, RJ; Filler, RM; Jaffe, N; Murray, J; Traggis, D; Watts, H; Weichselbaum, R; Weinstein, H | 1 |
| Jaffe, N | 1 |
| Plager, C; Sinkovics, JG | 1 |
| Meuret, G | 1 |
| Chabora, BM; Rosen, G; Tefft, M | 1 |
| Brown, BL; Lazarus, H; Modest, EJ; Sengupta, SK; Tinter, SK | 1 |
| Bacci, G; Pagani, PA | 1 |
| Galbraith, WM; Mellett, LB | 1 |
| Cangir, A; Sullivan, MP; Sutow, WW; Wilbur, JR | 1 |
| Applewhite, A; Healey, J; Heller, G; Huvos, A; Lane, J; Marcove, R; Meyers, PA; Rosen, G; Vlamis, V | 1 |
| Black, T; Estrada-Aguilar, J; Greenberg, H; Hvizdala, E; Morse, S; Schroer, K; Walling, A | 1 |
| Bunning, RA; Fawthrop, FW; Oyajobi, BO; Russell, RG | 1 |
| Blomqvist, C; Elomaa, I; Holmström, T; Karaharju, E; Laasonen, E; Ryöppy, S; Siimes, MA | 1 |
| Bröcheler, J; Mertens, R; Niedeggen, A; Röther, J; Weis, J | 1 |
| Eldridge, RM; Fleming, RA; Johnson, CE; Stewart, CF | 1 |
| Buchanan, GR; Pappo, A; Sanders, JM; Schneider, NR | 1 |
| Glasser, DB; Lane, JM | 1 |
| Alvegård, TA; Elomaa, I; Holmström, T; Saeter, G; Solheim, OP; Stenwig, AE | 1 |
| Abuchaibe, O; Antillon, F; Azinovic, I; Calvo, FA; Cañadell, J; Ortiz de Urbina, D; Santos, M; Sierrasesúmaga, L | 1 |
| Jurczyk-Procyk, S; Perek, D | 1 |
| Allan, EH; Fukumoto, S; Gelehrter, TD; Martin, TJ; Zeheb, R | 1 |
| Flanigan, P; Freshney, RI; Hamilton, TG; Kaye, SB; Merry, S | 1 |
| Allan, EH; Fukumoto, S; Gelehrter, TD; Heaton, JH; Martin, TJ; Yee, JA; Zeheb, R | 1 |
| Willnow, U | 1 |
| Aloe, L; Carlini, S; Cavaliere, F; Cavaliere, R; Cavallero, L; Di Filippo, F; Giannarelli, D; Moscarelli, F | 1 |
| Binderman, I; Kaye, AM; Mayer, H; Schlüter, KD; Sömjen, D; Wingender, E | 1 |
| Green, E; Heath, D; Todd, B | 1 |
| Delling, G; Knop, J; Montz, R; Stritzke, P; Winkler, K | 1 |
| Eschenbach, C; Maroske, D; Winkler, K | 1 |
| Delling, G; Hajek, P; Kotz, R; Kumpan, W; Lechner, G; Salzer-Kuntschik, M; Sekera, J; Wittich, GR | 1 |
| Huvos, AG; Marcove, R; Nirenberg, A; Rosen, G | 1 |
| Epelman, S; Jaffe, N; Pratt, CB | 1 |
| Dawson, P; Dean, L; Nachman, J; Shermeta, D; Simon, MA; Vogelzang, NJ | 1 |
| Bauters, F; Fenaux, P; Jouet, JP; Lai, JL; Lepelley, P | 1 |
| Berger, J; Beron, G; Delling, G; Gerein, V; Heise, U; Jürgens, H; Kabisch, H; Purfürst, C; Ritter, J; Winkler, K | 1 |
| Bachelot, C; Boitetot, A; Brunat-Mentigny, M; Demaille, MC; Gentet, JC; Noir, P; Olive, D; Quitana, E; Roche, H; Thyss, JP | 1 |
| Contesso, G; Dubousset, J; Kalifa, C; Lumbroso, J; Mlika, N; Vanel, D | 1 |
| Kettler, AH; Levy, ML; Scallan, PJ; Tschen, JA | 1 |
| Bielack, S; Delling, G; Knop, J; Winkler, K | 1 |
| Price, PA; Theofan, G | 1 |
| Beppu, Y; Chuman, H; Fukuma, H | 1 |
| Baranzelli, MC; Bouretz, JC; Demaille, MC; Dusol, F; Gosselin, P | 1 |
| Avella, M; Bacchini, P; Bacci, G; Bertoni, F; Campanacci, M; Dallari, D; Fontana, M; Mercuri, M; Pignatti, G | 1 |
| Heikkinen, E; Lanning, M; Lanning, P | 1 |
| Birkenhäger, JC; Pols, HA; Schilte, JP; Visser, TJ | 1 |
| Birkenhäger, JC; Pols, HA; Schilte, JP; van Leeuwen, JP; Visser, TJ | 1 |
| Avioli, LV; Birge, SJ; Kim, YS; Miller, R | 1 |
| Kamel, HM; Merry, S; Toner, PG | 1 |
| Butler, WT; Noda, M; Prince, CW; Rodan, GA; Yoon, K | 1 |
| Adachi, N; Fukuma, H; Hanada, M; Ohira, M; Takayama, J | 1 |
| D'Souza, SM; Mundy, GR; Pfeilschifter, J | 1 |
| Butler, WT; Prince, CW | 1 |
| Deftos, JL; Manolagas, SC; Price, PA; Spiess, YH | 1 |
| Billiau, A; Cayphas, S; Opdenakker, G; Van Damme, J; Van Snick, J | 1 |
| Majeska, RJ; Nair, BC; Rodan, GA | 1 |
| Atherton, E; Meienhofer, J; Patel, RP; Sano, Y | 1 |
| Ahmann, DL; Cupps, RE; Soule, EH | 1 |
| Freeman, JE; Malpas, JS | 1 |
| Balconi, G; Morasca, L | 1 |
| Ansfield, FJ; Davis, HL; Jaeschke, W; Ramirez, G; Wiley, AL; Wirtanen, GW; Wu, JP | 1 |
| Freckman, HA | 1 |
| Plüss, HJ | 1 |
| Fernandez, CH; Gottlieb, JA | 1 |
| Brown, BL; D'Angio, GJ; Farber, S; Maddock, CL | 1 |
| Brown, BL; D'Angio, GJ; Maddock, CL; Tefft, M | 1 |
| Philips, FS; Schwartz, HS; Sodergren, JE; Sternberg, SS | 1 |
| Schwartz, HS; Sodergren, JE | 1 |
| Ambaye, RY; Schwartz, HS; Sodergren, JE | 1 |
| Blodi, FC | 1 |
| Friedman, RM; Stern, R | 1 |
| Morasca, L; Roy-Camille, R | 1 |
| Meienhofer, J; Patel, RP | 1 |
7 review(s) available for dactinomycin and Osteogenic Sarcoma
| Article | Year |
|---|---|
[Soft tissue sarcoma: postoperative chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Administration Schedule; Humans; Ifosfamide; Melphalan; Mesna; Methotrexate; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2004 |
Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS).
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Protocols; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Germany; Humans; Ifosfamide; Immunologic Factors; Interferon-beta; Methotrexate; Multicenter Studies as Topic; Osteosarcoma; Prognosis; Randomized Controlled Trials as Topic; Treatment Outcome; Vincristine | 1993 |
Osteosarcoma of the extremities: chemotherapy experience at Memorial Sloan-Kettering.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Methotrexate; New York; Osteosarcoma; Prognosis; Proportional Hazards Models; Racial Groups; Retrospective Studies; Risk; Survival Rate; Treatment Outcome | 1993 |
The success and failure of multimodal therapy for cancer in children.
Topics: Adolescent; Age Factors; Child; Dactinomycin; Humans; Lymph Node Excision; Male; Methotrexate; Neoplasm Metastasis; Neoplasms; Neuroblastoma; Osteosarcoma; Prognosis; Retinoblastoma; Rhabdomyosarcoma; Sarcoma; Testicular Neoplasms; Vincristine; Wilms Tumor | 1975 |
[Therapy of sarcomas].
Topics: Adolescent; Adult; Bone Neoplasms; Child; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Methotrexate; Middle Aged; Osteosarcoma; Remission, Spontaneous; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 1978 |
Secondary myelodysplastic syndrome complicating therapy for osteogenic sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Methotrexate; Myelodysplastic Syndromes; Osteosarcoma | 1991 |
Proceedings: Recent progress in the chemotherapy of primary tumors of bone.
Topics: Antineoplastic Agents; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Humans; Osteosarcoma; Sarcoma, Ewing; Vincristine | 1972 |
19 trial(s) available for dactinomycin and Osteogenic Sarcoma
| Article | Year |
|---|---|
Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Humans; Leucovorin; Male; Methotrexate; Neoadjuvant Therapy; Osteosarcoma; Survival Analysis; Treatment Outcome | 2003 |
Adjuvant chemotherapy in osteosarcoma - effects of cisplatinum, BCD, and fibroblast interferon in sequential combination with HD-MTX and adriamycin. Preliminary results of the COSS 80 study.
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Cisplatin; Clinical Trials as Topic; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Interferons; Methotrexate; Osteosarcoma; Preoperative Care; Random Allocation | 1983 |
Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Female; Humans; Interferon Type I; Male; Methotrexate; Osteosarcoma; Prognosis | 1984 |
Primary osteogenic sarcoma of the femur: a model for the use of preoperative chemotherapy in high risk malignant tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Femoral Neoplasms; Humans; Leucovorin; Male; Methotrexate; Osteosarcoma; Premedication; Prognosis | 1984 |
The multi-institutional osteosarcoma study: an update.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Leucovorin; Life Tables; Methotrexate; Osteosarcoma; Survival Rate; Treatment Outcome; United States | 1993 |
Osteosarcoma in adolescents and young adults: new developments and controversies. The Childrens Cancer Group (CCG) studies.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Leucovorin; Methotrexate; Osteosarcoma; Survival Rate; Treatment Outcome; United States; Vincristine | 1993 |
Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli Institute.
Topics: Actuarial Analysis; Adolescent; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Extremities; Female; Humans; Italy; Male; Methotrexate; Necrosis; Osteosarcoma; Prognosis; Salvage Therapy; Survival Analysis | 1993 |
Chemotherapy in osteogenic sarcoma: the experience of the Pediatric Department of the Gustave Roussy Institute.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Feasibility Studies; Female; France; Humans; Ifosfamide; Leucovorin; Male; Methotrexate; Osteosarcoma; Survival Rate; Treatment Outcome; Vincristine | 1993 |
Osteosarcoma of the limb: an institutional report of 10 years experience with neoadjuvant chemotherapy and delayed surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Leucovorin; Life Tables; Methotrexate; Osteosarcoma; Treatment Outcome; Vincristine | 1993 |
Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Extremities; Humans; Methotrexate; Osteosarcoma; Vincristine | 1997 |
Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Humans; Male; Methotrexate; Necrosis; Osteosarcoma; Time Factors; Treatment Outcome | 1998 |
Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Humans; Lung Neoplasms; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Proportional Hazards Models; Risk Assessment | 2001 |
A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomas.
Topics: Adult; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Fibrosarcoma; Hemangiopericytoma; Histiocytoma, Benign Fibrous; Humans; Leiomyosarcoma; Lomustine; Male; Mesothelioma; Neurofibroma; Nitrosourea Compounds; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Triazenes; Vincristine | 1976 |
Study of adjuvant chemotherapy in osteogenic sarcoma.
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Female; Humans; Male; Neoplasm Metastasis; Osteosarcoma; Vincristine | 1975 |
Intraoperative radiotherapy in the multidisciplinary treatment of bone sarcomas in children and adolescents.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Humans; Intraoperative Period; Male; Methotrexate; Osteosarcoma; Prospective Studies; Recurrence; Remission Induction; Sarcoma, Ewing; Vincristine | 1991 |
[Alternative chemotherapy of malignant bone neoplasms in children].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Leucovorin; Methotrexate; Organoplatinum Compounds; Osteosarcoma; Sarcoma, Ewing; Vincristine | 1990 |
Bleomycin, cyclophosphamide, and dactinomycin in metastatic osteosarcoma: lack of tumor regression in previously treated patients.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Female; Humans; Male; Neoplasm Metastasis; Osteosarcoma | 1987 |
Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Methotrexate; Osteosarcoma; Postoperative Period; Preoperative Care; Prognosis; Random Allocation | 1988 |
[Scintigraphic follow-up of osteosarcoma during neoadjuvant chemotherapy. Results of the cooperative osteosarcoma study of the Society for Pediatric Oncology].
Topics: Adolescent; Adult; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Follow-Up Studies; Humans; Methotrexate; Multicenter Studies as Topic; Osteosarcoma; Radionuclide Imaging; Technetium Tc 99m Medronate | 1988 |
112 other study(ies) available for dactinomycin and Osteogenic Sarcoma
| Article | Year |
|---|---|
NMNAT1 Is a Survival Factor in Actinomycin D-Induced Osteosarcoma Cell Death.
Topics: Antibiotics, Antineoplastic; Apoptosis; Biomarkers, Tumor; Bone Neoplasms; Cell Proliferation; Dactinomycin; Gene Expression Regulation, Neoplastic; Humans; Nicotinamide-Nucleotide Adenylyltransferase; Osteosarcoma; Poly (ADP-Ribose) Polymerase-1; Sirtuin 1; Tumor Cells, Cultured | 2021 |
ABCG1 and Pgp identify drug resistant, self-renewing osteosarcoma cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; Bone Neoplasms; Cell Growth Processes; Cell Line, Tumor; Dactinomycin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; HEK293 Cells; Hep G2 Cells; Humans; MCF-7 Cells; Neoplastic Stem Cells; Osteosarcoma; RNA, Messenger; Vincristine | 2019 |
Effect of variation of ABCB1 and ABCC3 genotypes on the survival of bone tumor cases after chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Genotype; Humans; Male; Methotrexate; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Osteosarcoma; Polymorphism, Single Nucleotide; Prognosis; Survival Rate; Vincristine; Young Adult | 2013 |
RRP12 is a crucial nucleolar protein that regulates p53 activity in osteosarcoma cells.
Topics: Apoptosis; Cell Line, Tumor; Cell Nucleolus; Cell Survival; Dactinomycin; DNA Damage; Doxorubicin; Humans; Nuclear Proteins; Osteosarcoma; Tumor Suppressor Protein p53 | 2016 |
Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Infant; Kaplan-Meier Estimate; Leucovorin; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Osteosarcoma; Survival Rate; Vincristine; Young Adult | 2011 |
Glutathione S-transferase P1 and DNA polymorphisms influence response to chemotherapy and prognosis of bone tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cisplatin; Cyclophosphamide; Dactinomycin; DNA-Binding Proteins; DNA, Neoplasm; Doxorubicin; Endonucleases; Female; Glutathione S-Transferase pi; Humans; Male; Methotrexate; Neoplasm Staging; Osteosarcoma; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prognosis; Survival Rate; Vincristine; Xeroderma Pigmentosum Group D Protein; Young Adult | 2012 |
Laboratory and clinical observations with combined actinomycin D and x-radiation.
Topics: Dactinomycin; Humans; Neoplasms; Osteosarcoma; Radiation Effects; Radiotherapy; Sarcoma; Wilms Tumor; X-Rays | 1963 |
THE THERAPY OF SARCOMAS BY ISOLATION PERFUSION.
Topics: Aorta; Aorta, Abdominal; Bone Neoplasms; Carotid Arteries; Chemotherapy, Cancer, Regional Perfusion; Chondrosarcoma; Dactinomycin; Dogs; Fibrosarcoma; Iliac Artery; Iliac Vein; Leiomyosarcoma; Liposarcoma; Lymphoma, Non-Hodgkin; Melphalan; Mesothelioma; Neoplasms; Neuroblastoma; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Kaposi; Subclavian Artery; Vena Cava, Inferior | 1964 |
OSTEOGENIC SARCOMA OF THE MANDIBLE. REPORT OF CASE TREATED BY RADIATION AND CHEMOTHERAPY.
Topics: Bone Neoplasms; Cobalt Isotopes; Dactinomycin; Drug Therapy; Humans; Mandible; Mandibular Neoplasms; Melphalan; Methotrexate; Neoplasms; Osteomyelitis; Osteosarcoma; Pathology; Radiography; Radium; Sarcoma | 1964 |
A successful case of allogeneic bone marrow transplantation for osteosarcoma with multiple metastases of lung and bone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Femoral Neoplasms; Humans; Lung Neoplasms; Male; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Remission Induction; Transplantation, Homologous; Treatment Outcome | 2006 |
Cisplatin-induced hypomagnesemia and cardiac dysrhythmia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Gastroenteritis; Heart Arrest; Humans; Magnesium; Methotrexate; Osteosarcoma; Water-Electrolyte Imbalance | 2007 |
Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Contraindications; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Extremities; Female; Humans; Limb Salvage; Male; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Treatment Outcome | 2007 |
Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53-deficient and proficient human osteosarcoma cell lines.
Topics: Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Dactinomycin; Humans; Nucleic Acid Synthesis Inhibitors; Osteosarcoma; Retinoblastoma Protein; Ribosomes; RNA Interference; RNA, Ribosomal; Tumor Suppressor Protein p53 | 2007 |
[Preoperative adjuvant therapy for primary malignant bone tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Humans; Ifosfamide; Neoadjuvant Therapy; Neoplasm Metastasis; Osteosarcoma; Prognosis; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2007 |
[Initial chemotherapy and conservative surgery in the current treatment of osteosarcoma. Apropos of 24 cases].
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Humans; Leucovorin; Male; Methods; Methotrexate; Osteosarcoma; Vincristine | 1984 |
Numerical changes in the various peripheral white blood cells in children as a result of antineoplastic therapy.
Topics: Antineoplastic Agents; Basophils; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Eosinophils; Hodgkin Disease; Humans; Leukocyte Count; Leukocytes; Lymphocytes; Methotrexate; Monocytes; Neuroblastoma; Osteosarcoma; Rhabdomyosarcoma; Sarcoma, Ewing; Time Factors; Vincristine; Wilms Tumor | 1984 |
[Combination chemotherapy in osteogenic sarcoma: the Memorial Sloan-Kettering cancer center experience (author's transl)].
Topics: Adolescent; Adult; Bleomycin; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Preoperative Care | 1980 |
Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.
Topics: Antineoplastic Agents; Bleomycin; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Leucovorin; Methotrexate; Osteosarcoma; Prognosis; Time Factors | 1982 |
What has adjuvant chemotherapy of osteosarcoma achieved? Discussion paper.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Humans; Methotrexate; Osteosarcoma | 1983 |
The effect of transcriptional inhibitors on the bone gamma-carboxyglutamic acid protein response to 1,25-dihydroxyvitamin D3 in osteosarcoma cells.
Topics: Amanitins; Animals; Calcitriol; Calcium-Binding Proteins; Cell Line; Clone Cells; Cycloheximide; Dactinomycin; Kinetics; Osteocalcin; Osteosarcoma; Rats; Transcription, Genetic | 1984 |
The fate of liposome-entrapped actinomycin D in vivo and its therapeutic effect in a solid murine tumour [proceedings].
Topics: Animals; Dactinomycin; Drug Stability; Kinetics; Liposomes; Mice; Osteosarcoma; Phosphatidylcholines; Sarcoma, Experimental | 1980 |
The effect of liposome (phospholipid vesicle) entrapment of actinomycin D and methotrexate on the in vivo treatment of sensitive and resistant solid murine tumours.
Topics: Animals; Dactinomycin; Dose-Response Relationship, Drug; Drug Resistance; Female; Liposomes; Methotrexate; Mice; Mice, Inbred AKR; Osteosarcoma; Sarcoma, Experimental; Tissue Distribution | 1981 |
Concepts for controlling drug-resistant tumor cells.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Burden; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Resistance; Fluorouracil; Leukemia L1210; Leukemia P388; Mammary Neoplasms, Experimental; Mice; Osteosarcoma; Sarcoma, Experimental | 1980 |
Osteosarcoma following radiation treatment for meningioma: report of a case and effective treatment with chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Dactinomycin; Etoposide; Female; Gonadotropin-Releasing Hormone; Humans; Ifosfamide; Lung Neoplasms; Meningeal Neoplasms; Meningioma; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Osteosarcoma; Tamoxifen; Tomography, X-Ray Computed; Vincristine | 1994 |
A monocentric therapy study: an approach to optimize the results of the treatment of osteosarcoma by protocols based upon HDMTX, associated with systematic conservative surgery.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Follow-Up Studies; Humans; Ifosfamide; Leucovorin; Methotrexate; Middle Aged; Osteosarcoma; Pilot Projects; Remission Induction; Salvage Therapy; Treatment Outcome; Vincristine | 1993 |
Osteosarcoma: experience with the Rosen T10 protocol at RCH, Melbourne.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Leucovorin; Life Tables; Male; Methotrexate; Osteosarcoma; Survival Rate; Treatment Outcome; Victoria; Vincristine | 1993 |
Magnetic resonance relaxation times of normal tissue in the course of chemotherapy: a study in patients with bone sarcoma.
Topics: Adipose Tissue; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Muscles; Osteosarcoma; Preoperative Care; Sarcoma, Ewing; Vincristine | 1994 |
Hyperthermic isolation limb perfusion (HILP) in the management of extremity melanoma and sarcoma with particular reference to the dosage, pharmacokinetics, and toxicity of cisplatin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Combined Modality Therapy; Dacarbazine; Dactinomycin; Evaluation Studies as Topic; Extremities; Humans; Hyperthermia, Induced; Incidence; Melanoma; Melphalan; Neoplasm Metastasis; Osteosarcoma; Rhabdomyolysis; Skin Neoplasms; Treatment Outcome | 1993 |
Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and cyclophosphamide in osteosarcoma survivors.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Forced Expiratory Volume; Humans; Lung; Methotrexate; Osteosarcoma; Pulmonary Diffusing Capacity; Total Lung Capacity | 1996 |
Helix-loop-helix-type transcription factor (HES-1) is expressed in osteoblastic cells, suppressed by 1,25(OH)2 vitamin D3, and modulates 1,25(OH)2 vitamin D3 enhancement of osteopontin gene expression.
Topics: Animals; Blotting, Northern; Bone Neoplasms; Calcitriol; Cell Adhesion; Cell Division; Cycloheximide; Dactinomycin; DNA-Binding Proteins; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Gene Expression Regulation, Neoplastic; Helix-Loop-Helix Motifs; Nucleic Acid Synthesis Inhibitors; Osteoblasts; Osteopontin; Osteosarcoma; Protein Synthesis Inhibitors; Rats; RNA, Messenger; Sialoglycoproteins; TCF Transcription Factors; Transcription Factor 7-Like 1 Protein; Transcription Factors; Tumor Cells, Cultured; Up-Regulation | 1997 |
Primary intracerebral small-cell osteosarcoma in an adolescent girl: report of a case.
Topics: Adolescent; Antineoplastic Agents; Bleomycin; Brain Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Magnetic Resonance Imaging; Osteosarcoma; Radiotherapy, Adjuvant | 1997 |
Synthesis and cellular characterization of the detransformation agent, (-)-depudecin.
Topics: 3T3 Cells; Actins; Alkadienes; Animals; Bone Neoplasms; Cell Nucleus; Cell Transformation, Neoplastic; Cycloheximide; Cytoskeleton; Dactinomycin; Epoxy Compounds; Fatty Alcohols; Genes, ras; Magnetic Resonance Spectroscopy; Mice; Osteosarcoma; Protein Synthesis Inhibitors; Signal Transduction; Spectrophotometry, Infrared; Stereoisomerism; Tumor Cells, Cultured | 1995 |
Regulation of the transcription of parathyroid-hormone/parathyroid-hormone-related peptide receptor mRNA by dexamethasone in ROS 17/2.8 osteosarcoma cells.
Topics: Animals; Antineoplastic Agents, Hormonal; Bone Neoplasms; Cycloheximide; Dactinomycin; Dexamethasone; Half-Life; Osteosarcoma; Parathyroid Hormone-Related Protein; Protein Biosynthesis; Protein Synthesis Inhibitors; Proteins; Rats; Receptors, Parathyroid Hormone; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 1998 |
Green fluorescent protein tag for studies of drug-induced translocation of nucleolar protein RH-II/Gu.
Topics: Biological Transport; Carrier Proteins; Cell Nucleolus; Dactinomycin; Green Fluorescent Proteins; Humans; Luminescent Proteins; Nuclear Proteins; Osteosarcoma; Protein Inhibitors of Activated STAT; RNA Helicases; RNA Nucleotidyltransferases; Small Ubiquitin-Related Modifier Proteins; Toyocamycin; Tumor Cells, Cultured; Zinc Fingers | 1998 |
Identification of active substances from Streptomyces culture fluids using p53-independent expression of p21/WAF1/Cip1 gene and their mode of action.
Topics: Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Dactinomycin; Enzyme Inhibitors; Gene Expression Regulation, Bacterial; Genes, p53; Genes, Regulator; Genes, Reporter; Humans; Hydroxamic Acids; Luciferases; Microbial Sensitivity Tests; Osteosarcoma; Phosphotransferases; Protein Synthesis Inhibitors; RNA, Messenger; Sp1 Transcription Factor; Stomach Neoplasms; Streptomyces; Transfection; Transformation, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
Promoter specificity and stability control of the p53-related protein p73.
Topics: Adenovirus E1A Proteins; Bone Neoplasms; Cysteine Endopeptidases; Dactinomycin; DNA-Binding Proteins; GADD45 Proteins; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Genes, myc; Genes, p53; Genes, Reporter; Genes, Tumor Suppressor; Humans; Intracellular Signaling Peptides and Proteins; Multienzyme Complexes; Multigene Family; Neoplasm Proteins; Nuclear Proteins; Nucleic Acid Synthesis Inhibitors; Osteosarcoma; Promoter Regions, Genetic; Proteasome Endopeptidase Complex; Protein Isoforms; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Proto-Oncogene Proteins p21(ras); Recombinant Fusion Proteins; RNA Splicing; Sequence Deletion; Trans-Activators; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 1999 |
Inhibitors of protein synthesis and RNA synthesis protect against okadaic acid-induced apoptosis in human osteosarcoma cell line MG63 cells but not in Saos-2 cells.
Topics: Apoptosis; Cell Nucleus; Cycloheximide; Dactinomycin; DNA Fragmentation; Enzyme Inhibitors; Humans; Okadaic Acid; Osteosarcoma; Protein Synthesis Inhibitors; Puromycin; RNA; Tumor Cells, Cultured | 1999 |
[Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: results about 56 cases].
Topics: Adolescent; Adult; Alkaline Phosphatase; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; L-Lactate Dehydrogenase; Leucovorin; Magnetic Resonance Imaging; Male; Methotrexate; Osteosarcoma; Prospective Studies; Survival Analysis; Tomography, X-Ray Computed; Vincristine | 2000 |
Glucocorticoids induce a near-total suppression of hyaluronan synthase mRNA in dermal fibroblasts and in osteoblasts: a molecular mechanism contributing to organ atrophy.
Topics: Atrophy; Blotting, Northern; Cell Nucleus; Cells, Cultured; Cloning, Molecular; Dactinomycin; Dexamethasone; Dose-Response Relationship, Drug; Fibroblasts; Glucocorticoids; Glucuronosyltransferase; Glycosyltransferases; Hormone Antagonists; Humans; Hyaluronan Synthases; Membrane Proteins; Mifepristone; Nucleic Acid Synthesis Inhibitors; Osteoblasts; Osteosarcoma; RNA, Messenger; Skin; Time Factors; Transcription, Genetic; Transferases; Tumor Cells, Cultured; Uridine; Xenopus Proteins | 2000 |
Transient posterior encephalopathy induced by chemotherapy in children.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain; Child; Cyclophosphamide; Dactinomycin; Female; Humans; Hypertension; Magnesium Deficiency; Male; Methotrexate; Neurotoxicity Syndromes; Osteosarcoma; Radiopharmaceuticals; Remission Induction; Syndrome; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 2001 |
1,25-Dihydroxyvitamin D3 selectively translocates PKCalpha to nuclei in ROS 17/2.8 cells.
Topics: Blotting, Northern; Bone Neoplasms; Calcitriol; Calcium Channel Agonists; Cell Nucleus; Dactinomycin; Fluorescent Antibody Technique; Gene Expression; Humans; Immunoblotting; Isoenzymes; Osteocalcin; Osteosarcoma; Protein Kinase C; Protein Kinase C-alpha; RNA, Messenger; Subcellular Fractions; Tetradecanoylphorbol Acetate; Time Factors; Tumor Cells, Cultured | 2002 |
[Planning of chemotherapy in cancer of children].
Topics: Age Factors; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Neuroblastoma; Osteosarcoma; Rhabdomyosarcoma; Wilms Tumor | 1975 |
Combination chemotherapy with bleomycin, cyclophosphamide and dactinomycin for the treatment of osteogenic sarcoma.
Topics: Adolescent; Bleomycin; Bone Marrow; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Osteosarcoma; Vomiting | 1977 |
Comparative antitumor activity of actinomycin analogs in mice bearing Ridgway osteogenic sarcoma or P388 leukemia.
Topics: Animals; Antineoplastic Agents; Dactinomycin; Leukemia, Experimental; Mice; Mice, Inbred AKR; Mice, Inbred C57BL; Mice, Inbred DBA; Osteosarcoma; Sarcoma, Experimental | 1978 |
Malignant bone tumors: spindle-cell sarcomas.
Topics: Adolescent; Amputation, Surgical; Bleomycin; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Humans; Leucovorin; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Preoperative Care; Prostheses and Implants; Radiography; Vincristine | 1978 |
[Cytostatic treatment as supplement in osteosarcoma and Ewing's sarcoma. Preliminary communication (author's transl)].
Topics: Adolescent; Adult; Antineoplastic Agents; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Female; Humans; Long-Term Care; Male; Osteosarcoma; Prognosis; Sarcoma, Ewing; Vincristine | 1979 |
Simultaneous radiation and drug therapy: tumor response and toxicity.
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Dactinomycin; Doxorubicin; Female; Humans; Male; Neoplasms; Osteosarcoma; Radiotherapy; Rhabdomyosarcoma; Soft Tissue Neoplasms; Vincristine | 1977 |
Multidisciplinary treatment for childhood sarcoma.
Topics: Adolescent; Age Factors; Antineoplastic Agents; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infant; Leucovorin; Lymphatic Metastasis; Male; Methods; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 1977 |
Current concepts in the management of disseminated malignant bone disease in childhood.
Topics: Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Leucovorin; Methotrexate; Osteosarcoma; Sarcoma, Ewing; Vincristine | 1977 |
Bone sarcomas: clinical experience.
Topics: Age Factors; Bone Neoplasms; Chondrosarcoma; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Leucovorin; Osteosarcoma; Sarcoma, Ewing; Vincristine | 1977 |
Radiation in bone sarcomas: a re-evaluation in the era of intensive systemic chemotherapy.
Topics: Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Osteosarcoma; Radiation Tolerance; Radiotherapy Dosage; Radiotherapy, High-Energy; Sarcoma, Ewing; Vincristine | 1977 |
7-substituted actinomycin D analogs. Chemical and growth-inhibitory studies.
Topics: Animals; Dactinomycin; Humans; Lactobacillus; Leukemia L1210; Leukemia, Experimental; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred Strains; Osteosarcoma; Sarcoma, Experimental; Structure-Activity Relationship | 1975 |
[Supplementary antiblastic polychemotherapy in localized malignant bone tumors. I. Ewing's sarcoma and osteosarcoma].
Topics: Adolescent; Adult; Antineoplastic Agents; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Osteosarcoma; Sarcoma, Ewing; Vincristine | 1975 |
Management of malignant bone tumors in children and adolescents.
Topics: Adolescent; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Diagnosis, Differential; Doxorubicin; Drug Therapy, Combination; Female; Humans; Male; Neoplasm Metastasis; Osteosarcoma; Prognosis; Sarcoma, Ewing; Vincristine | 1976 |
Disposition of [3H]actinomycin D in tumor-bearing mice.
Topics: Animals; Dactinomycin; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred Strains; Osteosarcoma; Regression Analysis; Sarcoma, Experimental | 1976 |
Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Methotrexate; Osteosarcoma; Proportional Hazards Models; Risk Factors; Survival Analysis | 1992 |
Primary treatment of pelvic osteosarcoma. Report of five cases.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adjuvant; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Fluid Therapy; Follow-Up Studies; Humans; Ifosfamide; Injections, Intra-Arterial; Lung Neoplasms; Osteosarcoma; Pelvic Bones; Radiotherapy Dosage; Survival Rate | 1992 |
The effect of transforming growth factor beta on the plasminogen activator activity of normal human osteoblast-like cells and a human osteosarcoma cell line MG-63.
Topics: Bone Remodeling; Cells, Cultured; Cycloheximide; Dactinomycin; Electrophoresis, Polyacrylamide Gel; Humans; Indomethacin; Interleukin-1; Osteoblasts; Osteosarcoma; Recombinant Proteins; Tissue Plasminogen Activator; Transforming Growth Factor beta; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 1992 |
Ten years' experience in patients with osteogenic sarcoma in Finland.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Finland; Humans; Male; Methotrexate; Osteosarcoma; Survival Rate | 1990 |
Unusually long survival time after resection and irradiation of a brain metastasis from osteosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Femoral Neoplasms; Humans; Interferon Type I; Male; Methotrexate; Osteosarcoma; Prognosis | 1990 |
Disposition of high-dose methotrexate in an obese cancer patient.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Half-Life; Humans; Leucovorin; Methotrexate; Obesity; Osteosarcoma; Tibia; Vincristine | 1991 |
Stage IIB osteogenic sarcoma.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Clinical Protocols; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; New York City; Osteosarcoma; Osteotomy; Postoperative Care; Predictive Value of Tests; Preoperative Care; Survival Analysis; Survival Rate | 1991 |
Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arm; Bleomycin; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Leg; Male; Methotrexate; Osteosarcoma; Survival Analysis | 1991 |
Glucocorticoid regulation of plasminogen activator inhibitor-1 messenger ribonucleic acid and protein in normal and malignant rat osteoblasts.
Topics: Animals; Animals, Newborn; Blotting, Northern; Cell Line; Cells, Cultured; Cycloheximide; Dactinomycin; Dexamethasone; Dihydrotestosterone; Estradiol; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Kinetics; Osteoblasts; Osteosarcoma; Plasminogen Activators; Plasminogen Inactivators; Progesterone; Rats; RNA, Messenger | 1992 |
Circumvention of pleiotropic drug resistance in subcutaneous tumours in vivo with verapamil and clomipramine.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Clomipramine; Dactinomycin; Doxorubicin; Drug Resistance; Etoposide; Female; Male; Mice; Mice, Inbred AKR; Osteosarcoma; Verapamil; Vincristine | 1991 |
Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Topics: Animals; Cycloheximide; Dactinomycin; Fibrinolysin; Osteoblasts; Osteosarcoma; Plasminogen Activators; Plasminogen Inactivators; Protein Biosynthesis; Rats; RNA, Messenger; Tissue Plasminogen Activator; Transforming Growth Factor beta; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 1991 |
[Effect by proliferation kinetics of malignant tumors of children of hyperthermia].
Topics: Autoradiography; Bone Neoplasms; Cell Division; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Hot Temperature; Humans; In Vitro Techniques; Kidney Neoplasms; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Osteosarcoma; Rhabdomyosarcoma; Thymidine; Tritium; Uridine; Wilms Tumor | 1990 |
The role of hyperthermic perfusion in the treatment of tumors of the extremities.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Dactinomycin; Extracorporeal Circulation; Extremities; Humans; Hyperthermia, Induced; Melanoma; Melphalan; Neoplasm Recurrence, Local; Osteosarcoma; Sarcoma; Soft Tissue Neoplasms; Survival Rate | 1990 |
Stimulation by defined parathyroid hormone fragments of cell proliferation in skeletal-derived cell cultures.
Topics: Animals; Cell Division; Cell Line; Cells, Cultured; Creatine Kinase; Cyclic AMP; Cycloheximide; Dactinomycin; DNA Replication; Embryo, Mammalian; Enzyme Induction; Growth Plate; Humans; Kinetics; Osteoblasts; Osteosarcoma; Parathyroid Hormone; Peptide Fragments; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1990 |
Mechanism of glucocorticoid regulation of alkaline phosphatase gene expression in osteoblast-like cells.
Topics: Alkaline Phosphatase; Animals; Antibodies, Monoclonal; Blotting, Northern; Cell Line; Cycloheximide; Dactinomycin; Dexamethasone; Dichlororibofuranosylbenzimidazole; Drug Interactions; Gene Expression Regulation, Enzymologic; Molecular Probes; Osteoblasts; Osteosarcoma; Puromycin; Rats; RNA, Messenger; Transcription, Genetic | 1990 |
[Bone scintigraphy in assessing the success of chemotherapy in osteosarcoma].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone and Bones; Bone Neoplasms; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Diphosphonates; Drug Evaluation; Female; Humans; Male; Osteosarcoma; Preoperative Care; Radionuclide Imaging; Technetium; Technetium Tc 99m Medronate; Time Factors | 1985 |
[Successful treatment of several metachronous pulmonary metastases of a chondroblastic osteosarcoma].
Topics: Amputation, Surgical; Bleomycin; Child; Chondroblastoma; Cyclophosphamide; Dactinomycin; Female; Humans; Ifosfamide; Leucovorin; Lung Neoplasms; Methotrexate; Osteosarcoma; Tibia | 1985 |
The angiographic response of osteosarcoma following pre-operative chemotherapy.
Topics: Adolescent; Adult; Angiography; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Methotrexate; Osteosarcoma; Preoperative Care; Vincristine | 1986 |
Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Leucovorin; Male; Methotrexate; Osteosarcoma | 1986 |
Neoadjuvant chemotherapy for osteogenic sarcoma: a model for the treatment of other highly malignant neoplasms.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma | 1986 |
Disparate histologic responses in simultaneously resected primary and metastatic osteosarcoma following intravenous neoadjuvant chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Necrosis; Osteosarcoma; Postoperative Care; Preoperative Care; Vincristine | 1987 |
Translocation t(9;11)(p21;q23) with acute myelomonocytic leukemia after chemotherapy for osteosarcoma: good response to antileukemic drugs.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Leukemia, Myeloid, Acute; Methotrexate; Neoplasms, Multiple Primary; Osteosarcoma; Translocation, Genetic | 1987 |
[The reproduction in France of Rosen's protocol for osteosarcomas].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Female; Humans; Male; Methotrexate; Middle Aged; Osteosarcoma; Prognosis | 1988 |
[Experience with protocol T10 in the pediatric service at the Gustave-Roussy Institute].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Female; Humans; Infant; Male; Methotrexate; Osteosarcoma; Prognosis | 1988 |
Neutrophilic eccrine hidradenitis. Evidence implicating bleomycin as a causative agent.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Eccrine Glands; Female; Humans; Inflammation; Neutrophils; Osteosarcoma; Sweat Gland Diseases | 1988 |
Bone Gla protein messenger ribonucleic acid is regulated by both 1,25-dihydroxyvitamin D3 and 3',5'-cyclic adenosine monophosphate in rat osteosarcoma cells.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Bucladesine; Calcitriol; Calcium-Binding Proteins; Cell Count; Cholera Toxin; Colforsin; Cyclic AMP; Dactinomycin; Gene Expression Regulation; Osteocalcin; Osteosarcoma; Parathyroid Hormone; Pertussis Toxin; Rats; RNA, Messenger; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1989 |
[Preoperative systemic chemotherapy of patients with osteosarcoma: a preliminary study of nine cases].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Male; Methotrexate; Osteosarcoma; Premedication | 1989 |
[Mirror-image osteosarcoma of the radius. A case].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Follow-Up Studies; Humans; Methotrexate; Neoplasms, Multiple Primary; Osteosarcoma; Prognosis; Radius | 1989 |
Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for telangiectatic osteogenic sarcoma of the extremities.
Topics: Adolescent; Adult; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Arm; Bleomycin; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Female; Follow-Up Studies; Humans; Leg; Male; Methotrexate; Osteosarcoma; Postoperative Complications; Premedication | 1989 |
Secondary cerebral astrocytoma 3 years after diagnosis of primary osteogenic sarcoma: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bleomycin; Brain Neoplasms; Child; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Electroencephalography; Femoral Neoplasms; Humans; Male; Methotrexate; Neoplasms, Multiple Primary; Osteosarcoma | 1987 |
Evidence that the self-induced metabolism of 1,25-dihydroxyvitamin D-3 limits the homologous up-regulation of its receptor in rat osteosarcoma cells.
Topics: Animals; Calcitriol; Cell Line; Culture Media; Cycloheximide; Dactinomycin; Ketoconazole; Kinetics; Osteosarcoma; Rats; Receptors, Calcitriol; Receptors, Steroid; Tumor Cells, Cultured | 1988 |
Heterologous up-regulation of the 1,25-dihydroxyvitamin D3 receptor by parathyroid hormone (PTH) and PTH-like peptide in osteoblast-like cells.
Topics: Animals; Calcitriol; Cell Line; Cyclic AMP; Cycloheximide; Dactinomycin; Kinetics; Osteoblasts; Osteosarcoma; Parathyroid Hormone; Peptide Fragments; Rats; Receptors, Calcitriol; Receptors, Steroid; Teriparatide | 1988 |
Early manifestations of vitamin D effects in rat osteogenic sarcoma cells.
Topics: Animals; Bone Neoplasms; Calcitriol; Calcium; Cell Count; Cell Line; Dactinomycin; Dose-Response Relationship, Drug; Osteosarcoma; Rats; Tumor Cells, Cultured | 1987 |
Mechanism of actinomycin D-induced resistance in Ridgway osteogenic sarcoma: an ultrastructural study.
Topics: Animals; Cell Line; Dactinomycin; Disease Models, Animal; Drug Resistance; Female; Male; Mice; Microscopy, Electron; Osteosarcoma; Sarcoma, Experimental; Tumor Cells, Cultured | 1988 |
Transcriptional regulation of osteopontin production in rat osteosarcoma cells by type beta transforming growth factor.
Topics: Animals; Calcitriol; Collagen; Dactinomycin; Dexamethasone; Electrophoresis, Polyacrylamide Gel; Fibronectins; Half-Life; Kinetics; Osteoblasts; Osteopontin; Osteosarcoma; Peptides; Rats; RNA, Messenger; Sialoglycoproteins; Transcription, Genetic; Transforming Growth Factors; Tumor Cells, Cultured | 1988 |
[Autologous bone marrow transplantation in osteosarcoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Melphalan; Methotrexate; Osteosarcoma; Transplantation, Autologous | 1987 |
Effects of transforming growth factor-beta on osteoblastic osteosarcoma cells.
Topics: Alkaline Phosphatase; Animals; Calcitriol; Cell Division; Cell Line; Collagen; Cycloheximide; Dactinomycin; DNA; Growth Substances; Osteoblasts; Osteosarcoma; Peptides; Rats; Transforming Growth Factors | 1987 |
1,25-Dihydroxyvitamin D3 regulates the biosynthesis of osteopontin, a bone-derived cell attachment protein, in clonal osteoblast-like osteosarcoma cells.
Topics: Animals; Calcitriol; Dactinomycin; Electrophoresis, Polyacrylamide Gel; Molecular Weight; Osteoblasts; Osteopontin; Osteosarcoma; Phosphoproteins; Phosphorylation; Radioimmunoassay; Rats; Sialoglycoproteins | 1987 |
Phenotype-associated changes in the effects of 1,25-dihydroxyvitamin D3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells.
Topics: Alkaline Phosphatase; Animals; Calcitriol; Calcium-Binding Proteins; Cell Line; Clone Cells; Dactinomycin; Osteoblasts; Osteocalcin; Osteosarcoma; Phenotype; Rats; Time Factors | 1986 |
Interleukin 1 and poly(rI).poly(rC) induce production of a hybridoma growth factor by human fibroblasts.
Topics: Animals; B-Lymphocytes; Biological Products; Cell Line; Cells, Cultured; Concanavalin A; Cricetinae; Cricetulus; Cycloheximide; Cytokines; Dactinomycin; Female; Fibroblasts; Growth Substances; Humans; Hybridomas; Interferon Type I; Interleukin-1; Kinetics; L Cells; Leukocytes; Mice; Osteosarcoma; Ovary; Poly I-C; Skin | 1987 |
Glucocorticoid regulation of alkaline phosphatase in the osteoblastic osteosarcoma cell line ROS 17/2.8.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Alkaline Phosphatase; Animals; Cell Division; Cell Line; Cycloheximide; Dactinomycin; Dexamethasone; Isoproterenol; Kinetics; Osteoblasts; Osteosarcoma; Parathyroid Hormone; Rats | 1985 |
Synthesis of actinomycin D lactam, [1',1'-bis(L-threo- , -diaminobutyric acid)]actinomycin D.
Topics: Aminobutyrates; Animals; Antibiotics, Antineoplastic; Dactinomycin; Lactams; Lacticaseibacillus casei; Lactobacillus; Lethal Dose 50; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred Strains; Osteosarcoma; Sarcoma, Experimental | 1973 |
Treatment of pulmonary metastatic disease with radiation therapy and adjuvant actinomycin D. Preliminary observations.
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Cobalt Isotopes; Dactinomycin; Ependymoma; Female; Fibrosarcoma; Hemangiopericytoma; Hemangiosarcoma; Humans; Infusions, Parenteral; Liposarcoma; Lung Neoplasms; Male; Mesenchymoma; Osteosarcoma; Radiotherapy Dosage; Radiotherapy, High-Energy; Retrospective Studies; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Sarcoma, Synovial; Teratoma | 1969 |
Blood and neoplastic diseases. Solid tumours in children.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Diagnosis, Differential; Doxorubicin; Hodgkin Disease; Humans; Infant; Methods; Methotrexate; Neoplasms; Neuroblastoma; Nitrogen Mustard Compounds; Osteosarcoma; Prednisolone; Prognosis; Radiography; Retinoblastoma; Rhabdomyosarcoma; Sarcoma, Ewing; Vincristine; Wilms Tumor | 1974 |
Different sensitivity to actinomycin D of biopsies of human tumors cultivated in vitro.
Topics: Biopsy; Carcinoma; Cells, Cultured; Dactinomycin; Humans; Osteosarcoma; Sarcoma; Time Factors | 1973 |
Combined intra-arterial chemotherapy and radiotherapy with special reference to osteogenic sarcoma.
Topics: Adolescent; Angiography; Cobalt Radioisotopes; Dactinomycin; Female; Femur; Humans; Injections, Intra-Arterial; Male; Osteosarcoma; Radioisotope Teletherapy | 1974 |
Results in 169 patients with cancer of the head and neck treated by intra-arterial infusion therapy.
Topics: Antineoplastic Agents; Brachial Artery; Brachiocephalic Trunk; Carcinoma, Squamous Cell; Carotid Artery, Internal; Catheterization; Cyclophosphamide; Dactinomycin; Fluorouracil; Head; Head and Neck Neoplasms; Humans; Injections, Intra-Arterial; Laryngeal Neoplasms; Melanoma; Methods; Methotrexate; Mouth Neoplasms; Neoplasms; Osteosarcoma; Paranasal Sinus Neoplasms; Pharyngeal Neoplasms; Skin Neoplasms; Skull Neoplasms; Vinblastine | 1972 |
[Chemotherapy of bone tumors].
Topics: Antineoplastic Agents; Bone Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Osteosarcoma; Sarcoma, Ewing; Vincristine | 1973 |
The enhanced response of the Ridgway osteogenic sarcoma to roentgen radiation combined with actinomycin D.
Topics: Animals; Dactinomycin; Mice; Osteosarcoma; Sarcoma, Experimental | 1965 |
The effect of combined radiation and actinomycin D therapy on incompletely removed mouse tumors.
Topics: Animals; Dactinomycin; Osteosarcoma; Sarcoma, Experimental | 1966 |
Actinomycin D: effects on Ridgway osteogenic sarcoma in mice.
Topics: Animals; Dactinomycin; Injections, Intravenous; Intermittent Claudication; Mice; Osteosarcoma; Sarcoma, Experimental | 1966 |
Actinomycin D effects on nucleic acids during tumor regression.
Topics: Animals; Axilla; Carbon Isotopes; Colorimetry; Dactinomycin; DNA; DNA, Neoplasm; Female; Intestine, Small; Mice; Neoplasm Proteins; Neoplasm Transplantation; Osteosarcoma; Phosphorus Isotopes; Proteins; RNA; RNA, Neoplasm; Sarcoma, Experimental; Thymidine; Uridine | 1968 |
Actinomycin D: drug concentrations and actions in mouse tissues and tumors.
Topics: Animals; Chromatography, Paper; Dactinomycin; Female; Intestine, Small; Liver; Mice; Neoplasms, Experimental; Osteosarcoma; RNA; Salivary Glands; Spleen; Thymus Gland; Time Factors; Tritium; Uridine | 1968 |
Unusual orbital neoplasms.
Topics: Aged; Dactinomycin; Deafness; Diplopia; Female; Humans; Middle Aged; Myxosarcoma; Neoplasm Recurrence, Local; Orbital Neoplasms; Osteitis Deformans; Osteosarcoma; Radiography; Skull; Temporal Lobe | 1969 |
Double-stranded RNA synthesized in animal cells in the presence of actinomycin D.
Topics: Albinism; Animals; Burkitt Lymphoma; Cell Line; Centrifugation, Density Gradient; Chick Embryo; Chromatography, Gel; Dactinomycin; Fibroblasts; HeLa Cells; Hematologic Diseases; Hodgkin Disease; In Vitro Techniques; Infectious Mononucleosis; Kidney; Leukocytes; Light; Liver; Lymphocytes; Osteosarcoma; Rats; Ribonucleases; RNA; RNA, Neoplasm; Spleen; Tritium; Uridine | 1970 |
[In vitro study of the sensitivity of osteosarcoma to antineoplastic agents: the antimitogram].
Topics: Antineoplastic Agents; Culture Techniques; Dactinomycin; Osteosarcoma | 1971 |
Synthesis of an actinomycin analog with substituted lactone oxygens (1',1'-bis(L-,-diaminopropionic acid))-actinomycin C (C 1).
Topics: Amino Acids; Animals; Antineoplastic Agents; Benzyl Compounds; Chemical Phenomena; Chemistry; Dactinomycin; Formates; Lactams; Lactobacillus; Nitrobenzenes; Osteosarcoma; Propionates; Rats; Sarcoma, Experimental; Serine | 1971 |